trial · primary record
N-Acetyl Cysteine (NAC)
Primary Sclerosing Cholangitis (PSC)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 15 |
| Primary completion | 2029-06 |
| Primary endpoint | Change in Serum Alkaline Phosphatase (ALP) From Baseline to Week 16 |
| Registry ID | NCT07898839 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:38.231Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07898839
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.